4,102
Views
52
CrossRef citations to date
0
Altmetric
Radiotherapy

Towards individualized dose constraints: Adjusting the QUANTEC radiation pneumonitis model for clinical risk factors

, , , &
Pages 605-612 | Received 16 Jan 2013, Accepted 17 Jun 2013, Published online: 19 Aug 2013

References

  • Marks LB, Bentzen SM, Deasy JO, Kong FM, Bradley JD, Vogelius IS, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S70–6.
  • Palma DA, Senan S, Tsujino K, Barriger RB, Rengan R, Moreno M, et al. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 2012;85:444–450.
  • Bradley JD, Hope A, El Naqa I, Apte A, Lindsay PE, Bosch W, et al. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 2007;69:985–92.
  • Vogelius IR, Bentzen SM. A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis. Acta Oncol 2012;51:975–83.
  • Hope AJ, Lindsay PE, El Naqa I, Alaly JR, Vicic M, Bradley JD, et al. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 2006;65:112–24.
  • Tucker SL, Liu HH, Liao Z, Wei X, Wang S, Jin H, et al. Analysis of radiation pneumonitis risk using a generalized Lyman model. Int J Radiat Oncol Biol Phys 2008;72:568–74.
  • Tucker SL, Li M, Xu T, Gomez D, Yuan X, Yu J, et al. Incorporating single-nucleotide polymorphisms into the lyman model to improve prediction of radiation pneumonitis. Int J Radiat Oncol Biol Phys 2012;85:251–7.
  • Stenmark MH, Cai XW, Shedden K, Hayman JA, Yuan S, Ritter T, et al. Combining physical and biologic parameters to predict radiation-induced lung toxicity in patients with non-small-cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys 2012; 84:e217–22.
  • Barnett GC, Coles CE, Elliott RM, Baynes C, Luccarini C, Conroy D, et al. Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: A prospective analysis study. Lancet Oncol 2012;13:65–77.
  • Bentzen SM, Tucker SL. Quantifying the position and steepness of radiation dose-response curves. Int J Radiat Biol 1997;71:531–42.
  • Appelt AL, Vogelius IR. A method to adjust radiation dose-response relationships for clinical risk factors. Radiother Oncol 2012;102:352–4.
  • Deasy JO, Blanco AI, Clark VH. CERR: A computational environment for radiotherapy research. Med Phys 2003; 30:979–85.
  • Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 2007; 26:2389–430.
  • Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141–54.
  • Wolbers M, Koller MT, Witteman JC, Steyerberg EW. Prognostic models with competing risks: Methods and application to coronary risk prediction. Epidemiology 2009; 20:555–61.
  • Choudhury JB. Non-parametric confidence interval estimation for competing risks analysis: Application to contraceptive data. Stat Med 2002;21:1129–44.
  • R Core Team. R: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2012.
  • Gray B. cmprsk: Subdistribution analysis of competing risks. R package version 2.2–2. Available from: http://CRAN. R-project.org/package = cmprsk
  • Haibe-Kains B, Desmedt C, Sotiriou C, Bontempi G. A comparative study of survival models for breast cancer prognostication on microarray data: Does a single gene beat them all?Bioinformatics 2008;24:2200–8.
  • Tucker SL, Jin H, Wei X, Wang S, Martel MK, Komaki R, et al. Impact of toxicity grade and scoring system on the relationship between mean lung dose and risk of radiation pneumonitis in a large cohort of patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys 2010;77:691–8.
  • Bentzen SM, Vaeth M, Pedersen DE, Overgaard J. Why actuarial estimates should be used in reporting late normal-tissue effects of cancer treatment … now!. Int J Radiat Oncol Biol Phys 1995;32:1531–4; Discussion in: Int J Radiat Oncol Biol Phys 1995;32:1547, Int J Radiat Oncol Biol Phys 1996;35:197, Int J Radiat Oncol Biol Phys 1996;36:988–9.
  • Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol 2010;28:2181–90.
  • van Luijk P, Faber H, Meertens H, Schippers JM, Langendijk JA, Brandenburg S, et al. The impact of heart irradiation on dose-volume effects in the rat lung. Int J Radiat Oncol Biol Phys 2007;69:552–9.
  • Huang EX, Hope AJ, Lindsay PE, Trovo M, El Naqa I, Deasy JO, et al. Heart irradiation as a risk factor for radiation pneumonitis. Acta Oncol 2011;50:51–60.
  • Dang J, Li G, Ma L, Diao R, Zang S, Han C, et al. Predictors of grade ≥ 2 and grade ≥ 3 radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with three-dimensional conformal radiotherapy. Acta Oncol Epub 2012 Dec 3.
  • Tucker SL, Mohan R, Liengsawangwong R, Martel MK, Liao Z. Predicting pneumonitis risk: A dosimetric alternative to mean lung dose. Int J Radiat Oncol Biol Phys 2013; 85:522–7.
  • Liu F, Yorke ED, Belderbos JS, Borst GR, Rosenzweig KE, Lebesque JV, et al. Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols. Int J Radiat Oncol Biol Phys 2013;85:182–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.